Vaccines World Summit
23th -
24th
January 2024 | 
Novotel Hyderabad, India

Advancing Vaccine Business, Innovation and Technology to Facilitate Access to New Vaccines and Combat Threat in Developing Nations

23th -
24th
January 2024 | 
Novotel Hyderabad, India
đź“… Add to Google Calendar
0 +
Attendees
0 +
World Wide Companies
0 +
Companies From India, China, Africa, Brazil, and More!
0 +
In-Person Networking Hours
0 +
Case Studies

Vaccination programs save millions of lives each year globally. With more than 100 million children immunized each year, global immunization coverage has never been higher. Sources indicate that the worldwide market for vaccines is worth USD 41.4 Billion in 2021 and is estimated to reach USD 67.2 Billion in 2026 at a CAGR of 10.2% from 2021 to 2026. The key drivers driving the growth of this market are a high prevalence of diseases, rising government and nongovernment funding for vaccine development, increasing investments by companies, and increasing focus on immunization programs.

The economies of developing countries, for example, India is growing at a tremendous speed, and it is expected to grow 18% within the next decade to about USD 3 Billion by 2026. Emerging manufacturers play a critical role in the supply of vaccines of developing countries, particularly basic and some combination vaccines. 30% of UNICEF’s total procurement comes from emerging manufacturers. The decrease in vaccine prices can also be attributed to increased competition and higher production capacities for individual vaccines brought about by the entry of emerging market manufacturers, particularly in the underused vaccines market.

Vaccines World Summit 2024, for Developing Economies, aims to bring together key experts and decision-makers from vaccine manufacturers, governmental organizations, regulators, non-profit organizations, and solution providers together to aid in advancements in this industry with significantly higher collaboration.

Vaccines World Summit

.

.

.

.

.

.

.

.

.
.

THANK YOU TO OUR SPONSORS









SPEAKERS

Featuring esteemed voices from the biopharmaceutical sector. Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders. Don't miss this chance to broaden your understanding of this ever-evolving industry.

Abhimanyu-Saxena_photo_profile-2

Abhimanyu Saxena

Team Leader - Health Systems Strengthening

United Nations Development Programme
India
Ahmed-Ogwell-Ouma_photo_profile-3

Ahmed Ogwell Ouma

Dep. Director-General

Africa CDC
South Africa
Akhona-Tshangela_photo_profile-3

Akhona Tshangela

Program Coordinator, Partnerships for African Vaccine Manufacturing (PAVM)

Africa Centres for Disease Control and Prevention (CDC)
South Africa
Aykut-Ozdarendeli_photo_profile-2

Aykut Ozdarendeli

Professor

Erciyes University
Turkey
David C. Kaslow

David C. Kaslow

Director, Office of Vaccines Research and Review,

FDA
USA
GVJA-Harshavardhan_photo_profile

GVJA Harshavardhan

Director

Bharat Biotech
India
Haleh-Hamedifar_photo_profile-3

Haleh Hamedifar

Chairperson

CinnaGen
Iran
Hamideh-Aghajani_photo_profile-3

Hamideh Aghajani

Production / QHSE Manager in Biopharma

AryoGen Pharmed
Iran
Jaganathan-KS_photo_profile

Jaganathan KS

Deputy Director

Serum Institute of India
India
K.-Zaman_photo_profile-3

K. Zaman

Senior Scientist, Enteric and Respiratory Infections

International Centre for Diarrhoeal Disease Research
Bangladesh
Kapil-Maithal_photo_profile

Kapil Maithal

President – Vaccines & Diagnostics

Zydus Lifesciences
India
Kavita-Singh

Kavita Singh

Director South Asia

Drug for Neglected Diseases Initiative
India
Kumar-Gaurav_photo_profile-3

Kumar Gaurav

General Manager (Regulatory Affairs)

Panacea Biotec
India
Kutub-Mahmood_photo_profile-3

Kutub Mahmood

Scientific Director,

PATH
USA
Michael-Coleman

Michael Coleman

CEO

Metaclipse Therapeutics Corporation
USA
Nasser-Aghdami_photo_profile

Nasser Aghdami

Associated Professor,

Royan Institute
Iran
Neeraj-Jain_photo_profile-2

Neeraj Jain

Country Director India & Director South Asia

PATH
India
Panduranga-Pavuluri_photo_profile-2

Panduranga Pavuluri

Vice President Viral Vaccines

Biological E. Limited (BE)
India
Petro-Terblanche_photo_profile-2

Petro Terblanche

Managing Director

Afrigen Biologics (Pty) Ltd
South Africa
Prasad-Kulkarni_photo_profile-2

Prasad Kulkarni

Executive Director

Serum Institute of India Pvt Ltd
India
Pratik-Shah_photo_profile

Pratik Shah

Vice President Medical Affairs

Bharat Serums and Vaccines
India
Priyabrata-Pattnaik_photo_profile-3

Priyabrata Pattnaik

Deputy Managing Director

Indian Immunologicals
India
Rajan-Sriraman_photo_profile-3

Rajan Sriraman

Research Director

Reliance Life Sciences
India
Sai-D-Prasad_photo_profile-3

Sai D Prasad

Executive Director

Bharat Biotech
India
Sarah-McMullen_photo_profile

Sarah McMullen

Country Director

USFDA- India Office
India
Siddarth-Daga_photo_profile-3

Siddarth Daga

CEO

Vins Bioproducts Ltd
India
Tara-Prasad_photo_profile-2

Tara Prasad

Senior Manager, Centre for Health Emergency Strategy & Partnerships,

UNICEF
Denmark
Tolu-Disu_photo_profile-3

Tolu Disu

Director

African Vaccine Manufacturing Initiative (AVMI)
UK
Vivek-Bansal_photo_profile-3

Vivek Bansal

Associate Vice President

Biological E., Limited
India

DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

BIOPHARMA/BIG PHARMA/ACADEMIC
Limited Super (By 20th October 2023)
SGD 1,395

Limited Special (By 17th Nov 2023)
SGD 1,595 

Early Bird (By 15th Dec 2023)
SGD 1,795

Standard Price
SGD 1,995
Limited Group Packages
  • BUY2,GET3
  • BUY3,GET5
SOLUTION PROVIDER
Limited Super (By 20th October 2023)
SGD 2,795

Limited Special (By 17th Nov 2023)
SGD 2,995 

Early Bird (By 15th Dec 2023)
SGD 3,195

Standard Price
SGD 3,395
Group Discount for Solution Providers & General Public: 
Buy 3 and get 10% off, Buy 5 get 20% off, Buy 6 and above, get 25% off

Don't Just Take Our Word For It

HEAR FROM OUR CLIENTS

Talks were very interesting addressing subjects really important such as the balance of Th1 and Th2 cells as immune response of COVID-19 vaccines. I watched a lot watching and rewatching the videos too.

,  
 

Instituto Butantan

#BUZZ ABOUT THE EVENT

SIMILAR EVENTS

Download Post Event Report Form

Download Attendee List

Download Prospectus Document Form

Download Brochure Document Form

Sponsorship Form

Download Agenda Form

Download Featured Content Form

Customised Webinar/Webcast

Download Customised Events Brochure

Contact us for Third Party Email Services

Download Newsletter Press Kit

Download Network Meetings Prospectus

Download Media Kit Brochure

Download Form